Alx Oncology Holdings (ALXO) Debt Ratio (2019 - 2026)

Alx Oncology Holdings has reported Debt Ratio for 8 years, with the latest figure at 0.05 in Q1 2026.

• Quarterly Debt Ratio fell 42.12% year-over-year to 0.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.05 (down 42.12% YoY) and the FY2025 annual result came in at 0.17, up 146.35% from the prior year.
• Debt Ratio slipped to 0.05 in Q1 2026 per ALXO's latest filing, from 0.17 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.17 in Q4 2025 and troughed at 0.01 in Q2 2022.
• A 5-year average of 0.06 and a median of 0.05 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2026: Debt Ratio jumped 740.08% in 2022, then tumbled 42.12% in 2026.
• Over 5 years, Debt Ratio stood at 0.04 in 2022, then grew by 10.33% to 0.04 in 2023, then jumped by 68.65% to 0.07 in 2024, then soared by 146.35% to 0.17 in 2025, then plunged by 71.09% to 0.05 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.05, 0.17, and 0.12 for Q1 2026, Q4 2025, and Q3 2025 respectively.